SM 04755Alternative Names: SM04755
Latest Information Update: 20 Feb 2017
At a glance
- Originator Samumed
- Class Antineoplastics
- Mechanism of Action Wnt signalling pathway inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Colorectal cancer; Gastric cancer; Liver cancer; Pancreatic cancer
- Preclinical Psoriasis; Scleroderma; Tendinitis